Selecta Biosciences' GAAP loss for 9M 2021 was $37.926 million, down 29% from $53.43 million in the previous year. Revenue increased 11.9 times to $55.14 million from $4.646 million a year earlier.
Selecta Biosciences' GAAP loss for 9M 2021 was $37.926 million, down 29% from $53.43 million in the previous year. Revenue increased 11.9 times to $55.14 million from $4.646 million a year earlier. 
ir.selectabio.com
English (US) 